To the Editor First of all, we congratulate Pramanik et al for carrying out the first randomized clinical trial in the field of metronomic chemotherapy. However, we would like to raise some pertinent issues.
from Cancer via ola Kala on Inoreader http://ift.tt/2DDvzfN
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου